Moleculin Biotech Inc (NASDAQ: MBRX) kicked off on Tuesday, down -8.55% from the previous trading day, before settling in for the closing price of $7.25. Over the past 52 weeks, MBRX has traded in a range of $6.01-$91.25.
Annual sales at Healthcare sector company grew by 26.36% over the past five years. While this was happening, its average annual earnings per share was recorded 85.68%. With a float of $2.02 million, this company’s outstanding shares have now reached $2.07 million.
Moleculin Biotech Inc (MBRX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Moleculin Biotech Inc is 2.19%, while institutional ownership is 1.51%. The most recent insider transaction that took place on Jun 23 ’25, was worth 100,000. In this transaction Chief Financial Officer of this company bought 270,270 shares at a rate of $0.37, taking the stock ownership to the 287,587 shares. Before that another transaction happened on Jun 23 ’25, when Company’s CEO and President bought 675,675 for $0.37, making the entire transaction worth $250,000. This insider now owns 743,607 shares in total.
Moleculin Biotech Inc (MBRX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 85.68% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 57.07% during the next five years compared to 26.36% growth over the previous five years of trading.
Moleculin Biotech Inc (NASDAQ: MBRX) Trading Performance Indicators
Take a look at Moleculin Biotech Inc’s (MBRX) current performance indicators. Last quarter, stock had a quick ratio of 1.39.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -60.47, a number that is poised to hit -4.38 in the next quarter and is forecasted to reach -17.12 in one year’s time.
Technical Analysis of Moleculin Biotech Inc (MBRX)
Moleculin Biotech Inc (NASDAQ: MBRX) saw its 5-day average volume 0.71 million, a positive change from its year-to-date volume of 0.18 million. As of the previous 9 days, the stock’s Stochastic %D was 33.53%.
During the past 100 days, Moleculin Biotech Inc’s (MBRX) raw stochastic average was set at 4.00%, which indicates a significant decrease from 11.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.79 in the past 14 days, which was lower than the 1.18 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $10.95, while its 200-day Moving Average is $16.90. Nevertheless, the first resistance level for the watch stands at $7.35 in the near term. At $8.08, the stock is likely to face the second major resistance level. The third major resistance level sits at $8.65. If the price goes on to break the first support level at $6.05, it is likely to go to the next support level at $5.48. Assuming the price breaks the second support level, the third support level stands at $4.75.
Moleculin Biotech Inc (NASDAQ: MBRX) Key Stats
The company with the Market Capitalisation of 13.70 million has total of 2,036K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -21,760 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -25,400 K.
